Publicaciones (18) Publicaciones de Zaira Ortega Llorente

2021

  1. Boys-Specific Text-Comprehension Enhancement With Dual Visual-Auditory Text Presentation Among 12–14 Years-Old Students

    Frontiers in Psychology, Vol. 12

  2. Intelligence quotient, short-term memory and study habits as academic achievement predictors of elementary school: A follow-up study

    Studies in Educational Evaluation, Vol. 70

2019

  1. Contribution of altered endocannabinoid system to overactive mTORC1 signaling in focal cortical dysplasia

    Frontiers in Pharmacology, Vol. 9, Núm. JAN

2016

  1. Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin–proteasome system

    Acta Neuropathologica, Vol. 131, Núm. 3, pp. 411-425

2015

  1. CB1 Cannabinoid receptor-dependent activation of mTORC1/Pax6 signaling drives Tbr2 expression and basal progenitor expansion in the developing mouse cortex

    Cerebral Cortex, Vol. 25, Núm. 9, pp. 2395-2408

  2. La inteligencia emocional en el campo de la neuropsicología y educación

    Procesos e instrumentos de evaluación neuropsicológica educativa (Ministerio de educación, cultura y deporte), pp. 124-135

2014

  1. Ubiquitin-proteasome system involvement in huntington's disease

    Frontiers in Molecular Neuroscience, Vol. 7, Núm. SEP

2013

  1. The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: Involvement of the endocannabinoid system

    International Journal of Neuropsychopharmacology, Vol. 16, Núm. 6, pp. 1407-1419

2012

  1. CB 2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling

    Journal of Biological Chemistry, Vol. 287, Núm. 2, pp. 1198-1209

2011

  1. Animal Models for Huntington's Disease

    Animal models for neurodegenerative diseases (RSC Publishing), pp. 214-229

  2. Striatal-enriched protein tyrosine phosphatase expression and activity in huntington's disease: A STEP in the resistance to excitotoxicity

    Journal of Neuroscience, Vol. 31, Núm. 22, pp. 8150-8162

2010

  1. Acute polyglutamine expression in inducible mouse model unravels ubiquitin/proteasome system impairment and permanent recovery attributable to aggregate formation

    Journal of Neuroscience, Vol. 30, Núm. 10, pp. 3675-3688

  2. Modelos transgénicos

    Enfermedad de Huntington. Claves y respuestas para un desafío singular (Editorial Médica Panamericana), pp. 75-88

  3. Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism

    Free Radical Biology and Medicine, Vol. 49, Núm. 4, pp. 612-621

2009

  1. Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, Núm. 33, pp. 13986-13991

  2. Modelos animales de enfermedades neurodegenerativas: ejemplo de la enfermedad de Huntington

    Avances en neurociencia: neurotransmisores y patologías nerviosas (Real Academia Nacional de Farmacia), pp. 237-272

2007

  1. Is the ubiquitin-proteasome system impaired in Huntington's disease?

    Cellular and Molecular Life Sciences, Vol. 64, Núm. 17, pp. 2245-2257

2005

  1. The ubiquitin-proteasome system in Huntington's disease

    Neuroscientist, Vol. 11, Núm. 6, pp. 583-594